Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $75 Price Target
Portfolio Pulse from richadhand@benzinga.com
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Pfizer (NYSE:PFE) and maintained a $75 price target.
June 22, 2023 | 1:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Pfizer and maintained a $75 price target.
The reiteration of the Overweight rating and maintenance of the $75 price target by Cantor Fitzgerald's analyst indicates a positive outlook for Pfizer's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100